Cardiac Malformations Not Up With First-Trimester Ondansetron

WEDNESDAY, Dec. 19, 2018 -- First-trimester ondansetron use is associated with a small increased risk for oral cleft but no increased risk for congenital malformations or cardiac malformations, according to a study published in the Dec. 18 issue of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news